| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enliven Therapeutics, Inc. (ELVN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. ELVN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 890.4K | $40.16M | - | |
| CEO | 875.0K | $39.46M | - | |
| Other | 740.2K | $33.38M | - | |
| 10% | 245.7K | $11.08M | -281,408 | |
| COO | 215.0K | $9.70M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2025 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 1,000 | $22.66 | $22,655.00 | -4.2% | -10.8% | - | |
| Jul 7, 2025 | Patel Anish54 | Chief Operating Officer | Sell | 6,667 | $19.79 | $131,950.60 | -1.1% | +3.6% | - | |
| Jun 27, 2025 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 3,250 | $20.91 | $67,955.81 | -6.6% | -10.2% | - | |
| Jun 20, 2025 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sell | 12,500 | $21.40 | $267,457.50 | -1.3% | -6.5% | +111.7% | |
| Jun 17, 2025 | Kintz Samuel51 | President And CEO | Sell | 12,500 | $22.18 | $277,292.30 | -0.7% | -15.1% | +105.8% | |
| Jun 13, 2025 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 3,000 | $22.55 | $67,655.40 | -11.5% | -9.1% | +110.5% | |
| Jun 9, 2025 | Patel Anish54 | Chief Operating Officer | Sell | 6,667 | $20.34 | $135,574.05 | -1.1% | -1.6% | +77.5% | |
| Jun 3, 2025 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sell | 7,500 | $20.03 | $150,219.75 | -0.8% | -4.4% | +64.8% | |
| Jun 3, 2025 | Kintz Samuel51 | President And CEO | Sell | 7,500 | $20.05 | $150,351.75 | -0.8% | -4.4% | +64.8% | |
| May 27, 2025 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 3,250 | $16.18 | $52,593.45 | -12.4% | +24.7% | +159.0% |